Cutting through the haze: will Singapore's new legislation be effective? by Ewing, J. Jackson

Get full text
Get full text

Converging Peril : Climate Change and Conflict in the Southern Philippines by Ewing, J. Jackson

Get full text
Get full text

Effective study / by 433567 Ewing, J. M.

COP16 Cancún: shifting goals of climate negotiations by Ewing, J. Jackson, Kuntjoro, Irene A

Get full text
Get full text

SEDIMENT DISTRIBUTION AND CONTINENTAL MARGIN STRUCTURE IN GULF OF ALASKA by Embley, R, Ewing, J, Watts, A

The steam-engine and other heat-engines / by Ewing, J. A. (James Alfred), 1855-1935

Resolving Asia's food conundrum : dual strategy needed by Ewing, J. Jackson, Teng, Paul, Marga Escalar

Get full text
Get full text

Introduction to Laser Technology / by Hitz, C. Breck, author 551358, Ewing, J. J. (James J.), 1942-, author 551359, Hecht, Jeff author 299387

Guideline for the investigation and management of eosinophilia by Butt, N, Lambert, J, Ali, S, Beer, P, Cross, N, Duncombe, A, Ewing, J, Harrison, C, Knapper, S, McLornan, D, Mead, A, Radia, D, Bain, B

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline by McMullin, M, Harrison, C, Ali, S, Cargo, C, Chen, F, Ewing, J, Garg, M, Godfrey, A, Knapper, S, McLornan, D, Nangalia, J, Sekhar, M, Wadelin, F, Mead, A

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis by McMullin, M, Mead, A, Ali, S, Cargo, C, Chen, F, Ewing, J, Garg, M, Godfrey, A, Knapper, S, McLornan, D, Nangalia, J, Sekhar, M, Wadelin, F, Harrison, C

A retrospective real world evidence study to review the current treatment pathways for myelofibrosis from across the United Kingdom (the REALISM UK study) by Mead, A, Butt, N, Nagi, W, Whiteway, A, Kirkpatrick, S, Rinaldi, C, Roughley, C, Ackroyd, S, Ewing, J, Neelakantan, P, Garg, M, Harrison, C, Tucker, D, Collington, S, Chiu, G, Hickey, J, Somervaille, T

BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients by Kizilors, A, Jackson, S, Anwar, J, Sa, I, Ficinski, L, Mian, S, Best, S, Copland, M, Hassan, S, Mead, A, Ewing, J, Drummond, M, Papanikolaou, M, Ottmann, O, Thompson, M, Lea, N, De Lavallade, H

Centre for Non-Traditional Security Studies Year in Review 2010 by Li, Hongyan, Kaur, Manpavan Joth, Cook, Alistair David Blair, Caballero-Anthony, Mely, Ewing, J. Jackson, Gong, Lina, Hangzo, Pau Khan Khup, Durodie, Bill, Sofiah Jamil, Kuntjoro, Irene A., Maeztri, Devin, Ong, Suan Ee

Get full text
Get full text

Feasibility of recruitment of patients withMyeloproliferative Neoplasms into the TAPfunded TAMARIN study by Harrison, C, Mendez-Ferrer, S, Houlton, A, Sirovica, M, Drummond, M, McMullin, M, Mead, A, Milojkovic, D, Ewing, J, Cargo, C, Butt, N, Wadelin, F, Chen, F, Coppell, J, Francis, S, Narayanan, S, Knapper, S, Godfrey, A

A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study by Mead, AJ, Butt, NM, Nagi, W, Whiteway, A, Kirkpatrick, S, Rinaldi, C, Roughley, C, Ackroyd, S, Ewing, J, Neelakantan, P, Garg, M, Tucker, D, Murphy, J, Patel, H, Bains, R, Chiu, G, Hickey, J, Harrison, C, Somervaille, TCP

Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial by Harrison, C, Mead, A, Panchal, A, Fox, S, Yap, C, Gbandi, E, Houlton, A, Alimam, S, Ewing, J, Wood, M, Chen, F, Coppell, J, Panoskaltsis, N, Knapper, S, Ali, S, Hamblin, A, Scherber, R, Dueck, A, Cross, N, Mesa, R, McMullin, M

Correlation between treatment outcomes, baseline characteristics and molecular responses in the Majic study which compared Ruxolitinib to best available therapy in essential thromb... by Harrison, C, Mead, A, Fox, S, Panchal, A, Yap, C, Houlton, A, Aliman, S, Ewing, J, Wood, M, Chen, F, Coppell, J, Panoskaltsis, N, Knapper, S, Ali, S, Hamblin, A, Scherber, R, Geyer, H, Scotch, A, Dueck, A, Cross, N, Mesa, R, McMullin, M

Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline by McLornan, DP, Godfrey, AL, Green, A, Frewin, R, Arami, S, Brady, J, Butt, NM, Cargo, C, Ewing, J, Francis, S, Garg, M, Harrison, C, Innes, A, Khan, A, Knapper, S, Lambert, J, Mead, A, McGregor, A, Neelakantan, P, Psaila, B, Somervaille, TCP, Woodley, C, Nangalia, J, Cross, NCP, McMullin, MF

Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial by Harrison, CN, Nangalia, J, Boucher, R, Jackson, A, Yap, C, O'Sullivan, J, Fox, S, Ailts, I, Dueck, AC, Geyer, HL, Mesa, RA, Dunn, WG, Nadezhdin, E, Curto-Garcia, N, Green, A, Wilkins, B, Coppell, J, Laurie, J, Garg, M, Ewing, J, Knapper, S, Crowe, J, Chen, F, Koutsavlis, I, Godfrey, A, Arami, S, Drummond, M, Byrne, J, Clark, F, Mead-Harvey, C, Baxter, EJ, McMullin, MF, Mead, AJ